{
  "docId": "019de076-9d2b-76a8-843e-6686f2efe993",
  "docSlug": "264dd70dbc5f8f6fdd2a3dbf6f8c09b5",
  "documentTitle": "Exscientia | Investor Day Presentation Deck | 90 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 90,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "comparison_table",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9d2b-76a8-843e-6686f2efe993/9",
  "deckHref": "/decks/019de076-9d2b-76a8-843e-6686f2efe993",
  "deckJsonHref": "/decks/019de076-9d2b-76a8-843e-6686f2efe993.json",
  "deckAnchorHref": "/decks/019de076-9d2b-76a8-843e-6686f2efe993#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.02,
        "w": 0.45,
        "x": 0.076,
        "y": 0.94
      },
      "kind": "disclaimer",
      "text": "Does not include Exscientia-designed programmes that entered clinical trials through DSP collaboration",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5cf9f78b-0830-4b8a-89e3-79090eac5387",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.85,
        "x": 0.076,
        "y": 0.25
      },
      "kind": "table",
      "text": "Target, Phase, Target Market, Key Differentiation. CDK7, Phase 1/2, Multiple relapsed/refractory solid tumour indications, Precision designed PK/PD specific for mechanism; Identification of high-grade responders. PKC-theta, Phase 1, Multiple immunology indications, Better selectivity, improvements in whole blood potency and predicted human dose <200mg/day. LSD1, IND-enabling, SCLC, AML and potential additional indications, Optimised therapeutic index by combining reversibility with short-half life, as well as brain penetration to meet high patient need. MALT1, IND-enabling, Multiple haematology indications, Solved potential dose-limiting toxicity issue present in competitor compounds",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "51f1dea9-521b-4c74-9acf-e6372ba51bfd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.48,
        "x": 0.076,
        "y": 0.138
      },
      "kind": "title",
      "text": "Differentiated through design and personalised medicine",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ada08ab-eaf3-4bc9-828e-122335be64ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.076,
        "y": 0.068
      },
      "kind": "title",
      "text": "Why are our clinical candidates different?",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b34953c3-61ee-43c1-9f80-1fcdbcd60d9f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 4,
      "beatId": "6bcf15c0-6c27-4ba1-b4d0-3bb40c9a9b7c",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Interest",
      "beatSlug": "aida-interest",
      "evidence": "The presentation deck generates interest by highlighting Exscientia's approach and achievements",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 4,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "118b0da0-1893-4824-ac01-9db0319b9704",
      "evidence": "The presentation deck presents a clear logic chain, connecting Exscientia's approach to its benefits",
      "position": 0,
      "objective": "To present Exscientia's approach to precision medicine",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    },
    {
      "to": 9,
      "from": 5,
      "name": "Before After",
      "slug": "21-before-after",
      "bestFor": "Product demos, process improvements, ROI justification",
      "matchId": "c3e30e9b-2a2e-4188-bb02-04eb888939d6",
      "evidence": "The presentation deck uses before-after comparisons to highlight the benefits of Exscientia's approach",
      "position": 1,
      "objective": "To highlight the benefits of Exscientia's approach",
      "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
      "confidence": 0.7,
      "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}